Startseite Evaluation of hematological alterations after therapeutic use of dipyrone in healthy adults: a prospective study
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Evaluation of hematological alterations after therapeutic use of dipyrone in healthy adults: a prospective study

  • Ernane C. de Souza , Dalyara M. Matos , Milainy R. Viana , Marcela C.O. Alvim , Herval L. Bonfante , Alexandre F. Pinto und Jorge W.L. Nascimento EMAIL logo
Veröffentlicht/Copyright: 13. Februar 2018

Abstract

Background

Dipyrone is a non-narcotic analgesic/antipyretic widely used in some countries but prohibited in others due to suspected risk of agranulocytosis. The primary goal of this study was to evaluate hematological alterations in healthy adult volunteers after treatment with dipyrone.

Methods

The study enrolled 30 healthy volunteers of both genders, aged 19–37 years. They received tablets containing 500 mg of dipyrone sodium to be used four times daily for 7 consecutive days. Before the first administration, arterial pressure was measured and blood was collected in order to evaluate hematological baseline parameters. On the 8th day after the beginning of treatment, the volunteers had their blood pressure assessed once more and underwent a second blood draw. Total and specific leukocyte counts, creatinine, urea, aspartate aminotransferase (AST), alanine aminotransferase (ALT), erythrocytes, and platelets were quantitatively determined.

Results

No statistically significant difference was observed among total or specific leukocyte counts. Number of platelets, erythrocytes, hemoglobin, and hematocrit decreased after treatment. Diastolic pressure, mean arterial pressure (MAP), and urea concentration declined, while creatinine, AST, and ALT showed no significant alterations. It is noteworthy that, even for parameters that showed statistically significant changes, the highest and lowest values remained within the normal ranges.

Conclusions

Although dipyrone has historically been associated with agranulocytosis, leukocyte counts remained practically unchanged after oral administration of dipyrone. On the other hand, the present study adds evidence that dipyrone is able to produce statistically relevant decrease in number of platelets, erythrocytes, hemoglobin, and hematocrit in healthy adults, even after short-term treatment.

  1. Author contributions: All authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by the Federal University of Juiz de Fora.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Hinz B, Cheremina O, Bachmakov J, Renner B, Zolk O, Fromm MF, et al. Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic. Faseb J 2007;21:2343–51.10.1096/fj.06-8061comSuche in Google Scholar

2. Aguirre-Banuelos P, Granados-Soto V. Evidence for a peripheral mechanism of action for the potentiation of the antinociceptive effect of morphine by dipyrone. J Pharmacol Toxicol Methods 1999;42:79–85.10.1016/S1056-8719(00)00046-0Suche in Google Scholar

3. Hamerschlak N, Maluf E, Biasi Cavalcanti A, Avezum Junior A, Eluf-Neto J, Passeto Falcao R, et al. Incidence and risk factors for agranulocytosis in Latin American countries– the Latin Study: a multicenter study. Eur J Clin Pharmacol 2008;64:921–9.10.1007/s00228-008-0513-7Suche in Google Scholar

4. Bakke OM, Manocchia M, de Abajo F, Kaitin KI, Lasagna L. Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective. Clin Pharmacol Ther 1995;58:108–17.10.1016/0009-9236(95)90078-0Suche in Google Scholar

5. No authors listed. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. J Am Med Assoc 1986;256:1749–57. Available at: https://www.ncbi.nlm.nih.gov/pubmed/3747087.10.1001/jama.1986.03380130077032Suche in Google Scholar

6. Maluf E, Hamerschlak N, Cavalcanti AB, Junior AA, Eluf-Neto J, Falcao RP, et al. Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study. Haematologica 2009;94:1220–6.10.3324/haematol.2008.002642Suche in Google Scholar PubMed PubMed Central

7. Ibanez L, Vidal X, Ballarin E, Laporte JR. Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol 2005;60:821–9.10.1007/s00228-004-0836-ySuche in Google Scholar PubMed

8. Martinez C, Andreu I, Amo G, Miranda MA, Esguevillas G, Torres MJ, et al. Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole. Biochem Pharmacol 2014;92:457–66.10.1016/j.bcp.2014.09.005Suche in Google Scholar PubMed

9. Derry S, Faura C, Edwards J, McQuay HJ, Moore RA. Single dose dipyrone for acute postoperative pain. Cochrane Database Syst Rev 2010;9:CD003227.10.1002/14651858.CD003227.pub2Suche in Google Scholar PubMed PubMed Central

10. Duarte Souza JF, Lajolo PP, Pinczowski H, del Giglio A. Adjunct dipyrone in association with oral morphine for cancer-related pain: the sooner the better. Support Care Cancer 2007;15: 1319–23.10.1007/s00520-007-0327-7Suche in Google Scholar PubMed

11. Horobin RW, Walter KJ. Understanding Romanowsky staining. I: the Romanowsky-Giemsa effect in blood smears. Histochemistry 1987;86:331–6.10.1007/BF00490267Suche in Google Scholar

12. Basak GW, Drozd-Sokolowska J, Wiktor-Jedrzejczak W. Update on the incidence of metamizole sodium-induced blood dyscrasias in Poland. J Int Med Res 2010;38:1374–80.10.1177/147323001003800419Suche in Google Scholar

13. Andrade SE, Martinez C, Walker AM. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol 1998;51:1357–65.10.1016/S0895-4356(98)00076-6Suche in Google Scholar

14. Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. Idiosyncratic drug-induced agranulocytosis: update of an old disorder. Eur J Intern Med 2006;17:529–35.10.1016/j.ejim.2006.07.012Suche in Google Scholar PubMed

15. Sabatowski R, Schafer D, Kasper SM, Brunsch H, Radbruch L. Pain treatment: a historical overview. Curr Pharm Des 2004;10:701–16.10.2174/1381612043452974Suche in Google Scholar PubMed

16. Tak T, Tesselaar K, Pillay J, Borghans JA, Koenderman L. What’s your age again? Determination of human neutrophil half-lives revisited. J Leukoc Biol 2013;94:595–601.10.1189/jlb.1112571Suche in Google Scholar PubMed

17. Polzin A, Zeus T, Schror K, Kelm M, Hohlfeld T. Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease. J Am Coll Cardiol 2013;62:1725–6.10.1016/j.jacc.2013.07.039Suche in Google Scholar PubMed

18. Weinberger I, Joshua H, Friedmann J, Rahamim S, Agmon J. Inhibition of ADP-induced platelet aggregation by dipyrone in patients with acute myocardial infarction. Thromb Haemost 1979;42:752–6.10.1055/s-0038-1666913Suche in Google Scholar

19. Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 2002;58:265–74.10.1007/s00228-002-0465-2Suche in Google Scholar PubMed

20. Redondo-Pachon MD, Enriquez R, Sirvent AE, Millan I, Romero A, Amoros F. Acute renal failure and severe thrombocytopenia associated with metamizole. Saudi J Kidney Dis Transpl 2014;25:121–5.10.4103/1319-2442.124524Suche in Google Scholar PubMed

21. Diaz-Quijano FA, Villar-Centeno LA, Martinez-Vega RA. Effectiveness of early dipyrone administration on severity of dengue virus infection in a prospective cohort. Enferm Infecc Microbiol Clin 2005;23:593–7.10.1157/13081567Suche in Google Scholar

22. Bozzo J, Escolar G, Hernandez MR, Galan AM, Ordinas A. Prohemorrhagic potential of dipyrone, ibuprofen, ketorolac, and aspirin: mechanisms associated with blood flow and erythrocyte deformability. J Cardiovasc Pharmacol 2001;38:183–90.10.1097/00005344-200108000-00003Suche in Google Scholar

23. Graff J, Arabmotlagh M, Cheung R, Geisslinger G, Harder S. Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study. Clin Ther 2007;29:438–47.10.1016/S0149-2918(07)80082-8Suche in Google Scholar

24. Geisslinger G, Peskar BA, Pallapies D, Sittl R, Levy M, Brune K. The effects on platelet aggregation and prostanoid biosynthesis of two parenteral analgesics: ketorolac tromethamine and dipyrone. Thromb Haemost 1996;76:592–7.10.1055/s-0038-1650627Suche in Google Scholar

25. Kramer M. Chronic toxicity of pyrazolones: the problem of nitrosation. Br J Clin Pharmacol 1980;10:313–7.10.1111/j.1365-2125.1980.tb01815.xSuche in Google Scholar PubMed PubMed Central

26. Imagawa VH, Fantoni DT, Tatarunas AC, Mastrocinque S, Almeida TF, Ferreira F, et al. The use of different doses of metamizol for post-operative analgesia in dogs. Vet Anaesth Analg 2011;38:385–93.10.1111/j.1467-2995.2011.00617.xSuche in Google Scholar PubMed

27. Ackerman Z, Flugelman MY, Wax Y, Shouval D, Levy M. Hepatitis during measles in young adults: possible role of antipyretic drugs. Hepatology 1989;10:203–6.10.1002/hep.1840100214Suche in Google Scholar PubMed

28. Hoigne R, Zoppi M, Sollberger J, Hess T, Fritschy D. Fall in systolic blood pressure due to metamizol (dipyrone, noramidopyrine, novaminsulfone). Results from the Comprehensive Hospital Drug Monitoring Berne (CHDMB). Agents Actions Suppl 1986;19:189–95.Suche in Google Scholar

29. Vera P, Zapata L, Gich I, Mancebo J, Betbese AJ. Hemodynamic and antipyretic effects of paracetamol, metamizol and dexketoprofen in critical patients. Med Intensiva 2012;36:619–25.10.1016/j.medine.2012.12.002Suche in Google Scholar

30. Gozzoli V, Treggiari MM, Kleger G-R, Roux-Lombard P, Fathi M, Pichard C, et al. Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Med. 2004;30:401–7.10.1007/s00134-003-2087-2Suche in Google Scholar PubMed

31. Escobar W, Ramirez K, Avila C, Limongi R, Vanegas H, Vazquez E. Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats. Eur J Pain 2012;16:676–89.10.1002/j.1532-2149.2011.00057.xSuche in Google Scholar PubMed

32. Jasiecka A, Maslanka T, Jaroszewski JJ. Pharmacological characteristics of metamizole. Pol J Vet Sci 2014;17:207–14.10.2478/pjvs-2014-0030Suche in Google Scholar PubMed

33. Lindenfeld J, Schrier RW. Blood urea nitrogen a marker for adverse effects of loop diuretics? J Am Coll Cardiol 2011;58:383–5.10.1016/j.jacc.2011.01.054Suche in Google Scholar PubMed

34. Batiushin MM, Dmitrieva OV, Terent’ev VP, Davidenko KS. Estimated methods of predicting risk of analgetic interstitial renal disease. Ter Arkh 2008;80:62–5.Suche in Google Scholar

35. Abu-Kishk I, Goldman M, Mordish Y, Berkovitch M, Kozer E. Transient renal insufficiency following dipyrone overdose. Arch Dis Child 2010;95:233–4.10.1136/adc.2009.171793Suche in Google Scholar PubMed

Received: 2017-03-22
Accepted: 2017-12-15
Published Online: 2018-02-13
Published in Print: 2018-07-26

©2018 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Letter to the Editor
  3. Blister-packed levothyroxine sodium or bottle-packed levothyroxine sodium
  4. Metabolism
  5. Comparative hypoglycemic potentials and phytochemical profiles of 12 common leafy culinary vegetables consumed in Nsukka, Southeastern Nigeria
  6. Infection
  7. The effects of oral pregabalin on post-Lichtenstein herniorrhaphic pain: a randomized clinical trial
  8. Cardiovascular Function
  9. Influence of age and gender on blood pressure variability and baroreflex sensitivity in a healthy population in the Indian sub-continent
  10. Autonomic responses during acute myocardial infarction in the rat model: implications for arrhythmogenesis
  11. Phytotherapy
  12. Role of reactive oxygen species–total antioxidant capacity status in Telfairia occidentalis leaves–associated spermatoprotective effect: a pointer to fatty acids benefit
  13. Antidiabetic and renoprotective effect of Anogeissus acuminata leaf extract on experimentally induced diabetic nephropathy
  14. Oxidative Stress
  15. Aged coconut oil with a high peroxide value induces oxidative stress and tissue damage in mercury-treated rats
  16. Anti-ulcerogenic effect of the methanol extract of Chasmanthera dependens (Hochst) stem on male Wistar rats
  17. Hematological Profile
  18. Evaluation of hematological alterations after therapeutic use of dipyrone in healthy adults: a prospective study
  19. Hematology and erythrocyte osmotic fragility of the Franquet’s fruit bat (Epomops franqueti)
  20. Behavior and Neuroprotection
  21. Haloperidol-induced parkinsonism is attenuated by varenicline in mice
  22. Antioxidant-mediated neuroprotection by Allium schoenoprasum L. leaf extract against ischemia reperfusion-induced cerebral injury in mice
  23. Effects of acetone extract of Cola nitida on brain sodium-potassium adenosine triphosphatase activity and spatial memory in healthy and streptozotocin-induced diabetic female Wistar rats
  24. Case Report
  25. Conservative treatment of postoperative chylothorax: a case report
  26. Short Communication
  27. Improved serotonergic neurotransmission by genistein pretreatment regulates symptoms of obsessive-compulsive disorder in streptozotocin-induced diabetic mice
Heruntergeladen am 30.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2017-0037/html
Button zum nach oben scrollen